ACA
Avoro Capital Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169M | Sell |
5,400,000
-341,666
| -6% | -$10.7M | 2.96% | 12 |
|
|
2025
Q1 | $193M | Buy |
5,741,666
+75,000
| +1% | +$2.52M | 3.01% | 9 |
|
|
2024
Q4 | $222M | Hold |
5,666,666
| – | – | 3.14% | 10 |
|
|
2024
Q3 | $223M | Hold |
5,666,666
| – | – | 3.25% | 11 |
|
|
2024
Q2 | $221M | Hold |
5,666,666
| – | – | 2.94% | 14 |
|
|
2024
Q1 | $244M | Hold |
5,666,666
| – | – | 2.85% | 14 |
|
|
2023
Q4 | $261M | Buy |
5,666,666
+766,666
| +16% | +$35.3M | 3.61% | 14 |
|
|
2023
Q3 | $167M | Hold |
4,900,000
| – | – | 2.61% | 14 |
|
|
2023
Q2 | $189M | Hold |
4,900,000
| – | – | 2.56% | 15 |
|
|
2023
Q1 | $175M | Hold |
4,900,000
| – | – | 2.6% | 13 |
|
|
2022
Q4 | $193M | Hold |
4,900,000
| – | – | 2.89% | 13 |
|
|
2022
Q3 | $177M | Hold |
4,900,000
| – | – | 3.27% | 12 |
|
|
2022
Q2 | $149M | Sell |
4,900,000
-85,000
| -2% | -$2.59M | 2.95% | 12 |
|
|
2022
Q1 | $152M | Hold |
4,985,000
| – | – | 2.78% | 13 |
|
|
2021
Q4 | $156M | Buy |
4,985,000
+1,335,000
| +37% | +$41.7M | 2.65% | 12 |
|
|
2021
Q3 | $55.8M | Hold |
3,650,000
| – | – | 0.88% | 22 |
|
|
2021
Q2 | $68M | Hold |
3,650,000
| – | – | 1.18% | 18 |
|
|
2021
Q1 | $65.3M | Buy |
3,650,000
+850,000
| +30% | +$15.2M | 1.13% | 19 |
|
|
2020
Q4 | $43.1M | Hold |
2,800,000
| – | – | 0.74% | 26 |
|
|
2020
Q3 | $31M | Hold |
2,800,000
| – | – | 0.44% | 29 |
|
|
2020
Q2 | $35.1M | Buy |
2,800,000
+28,000
| +1% | +$351K | 0.69% | 29 |
|
|
2020
Q1 | $31.4M | Buy |
2,772,000
+372,000
| +16% | +$4.22M | 1.06% | 22 |
|
|
2019
Q4 | $31.5M | Hold |
2,400,000
| – | – | 0.92% | 20 |
|
|
2019
Q3 | $21.6M | Hold |
2,400,000
| – | – | 0.9% | 24 |
|
|
2019
Q2 | $23.7M | Hold |
2,400,000
| – | – | 0.82% | 24 |
|
|
2019
Q1 | $24.4M | Hold |
2,400,000
| – | – | 1.05% | 21 |
|
|
2018
Q4 | $15.1M | Buy |
2,400,000
+32,782
| +1% | +$207K | 0.91% | 21 |
|
|
2018
Q3 | $31.2M | Buy |
2,367,218
+1,165,100
| +97% | +$15.4M | 1.43% | 19 |
|
|
2018
Q2 | $11.1M | Buy |
+1,202,118
| New | +$11.1M | 0.43% | 33 |
|